Biopharmaceutical Analysis & Statistics in North America Countries, April 2012 (p7)

You might be interested in: biomedical, protein, antibody, more »

181-210 of about 300 reports

Purchase Reports From Reputable Market Research Publishers

Enzymes: Canada : Focus report

Enzymes: Canada : Focus report

  • $ 850
  • Industry report
  • April 2012
  • by Freedonia Focus

This report discusses enzyme demand in Canada for the years 2005 and 2010, with forecasts for 2015. Topics covered include overview of products; overview of markets; economic trends and supply and demand ...

  • Industries : Biopharmaceutical
  • Countries : Canada
Enzymes: Mexico : Focus report

Enzymes: Mexico : Focus report

  • $ 850
  • Industry report
  • April 2012
  • by Freedonia Focus

This report discusses enzyme demand in Mexico for the years 2005 and 2010, with forecasts for 2015. Topics covered include overview of products; overview of markets; economic trends and supply and demand ...

  • Industries : Biopharmaceutical
  • Countries : Mexico
SDIX (SDIX) - Financial and Strategic SWOT Analysis Review

SDIX (SDIX) - Financial and Strategic SWOT Analysis Review

  • $ 250
  • Company report
  • March 2012
  • by Global Data

SDIX (formerly Strategic Diagnostics Inc.) is a biotechnology company engaged in developing, manufacturing and commercializing antibody products and analytical test kits utilized in agricultural, food, ...

  • Industries : Biopharmaceutical
  • Countries : United States
Medical & Biological Laboratories Co., Ltd. (Symbol:4557) SWOT Analysis, Strategy, Revenues and Profits

Medical & Biological Laboratories Co., Ltd. (Symbol:4557) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Japan
Strategic Analysis of the U.S. Research Antibodies Market

Strategic Analysis of the U.S. Research Antibodies Market

  • $ 6 000
  • Industry report
  • March 2012
  • by Frost & Sullivan

This research service evaluates the U.S. research antibodies market during the 2009 to 2016 time period. The research antibodies market includes all antibodies sold for research use only to be used as ...

  • Industries : Biopharmaceutical
  • Countries : United States
Pacgen Biopharmaceuticals Corporation (Symbol:PGA) SWOT Analysis, Strategy, Revenues and Profits

Pacgen Biopharmaceuticals Corporation (Symbol:PGA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada
Investment Confidence Among Laboratory Decision Makers

Investment Confidence Among Laboratory Decision Makers

  • $ 10 000
  • Industry report
  • March 2012
  • by Frost & Sullivan

The study investigates investment decisions of healthcare-related laboratory decision makers. It shows that 2011 was tumultuous for the laboratory industry. In comparison, the outlook for 2012 looks only ...

  • Industries : Biopharmaceutical
  • Countries : United States
Neose Technologies, Inc. (Inactive): Pharmaceuticals and Healthcare Company Profile, SWOT Report

Neose Technologies, Inc. (Inactive): Pharmaceuticals and Healthcare Company Profile, SWOT Report

  • $ 125
  • Company report
  • March 2012
  • by ICD Research

Synopsis ICD Research's "Neose Technologies, Inc. (Inactive): Pharmaceuticals and Healthcare Company Profile, SWOT Report" contains in depth information and data about the company and its operations. ...

  • Industries : Biopharmaceutical
  • Countries : United States
Burcon NutraScience Corporation: Ingredients Company Profile, SWOT & Financial Report

Burcon NutraScience Corporation: Ingredients Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • March 2012
  • by Canadean Ltd

Synopsis Canadean's "Burcon NutraScience Corporation: Ingredients Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains ...

  • Industries : Cereal Production, Biopharmaceutical
  • Countries : Canada
BioExx Specialty Proteins Ltd.: Ingredients Company Profile, SWOT & Financial Report

BioExx Specialty Proteins Ltd.: Ingredients Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • March 2012
  • by Canadean Ltd

Synopsis Canadean's "BioExx Specialty Proteins Ltd.: Ingredients Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains ...

  • Industries : Biopharmaceutical
  • Countries : Canada
SunOpta BioProcess Inc. - Alternative Energy - Deals and Alliances Profile

SunOpta BioProcess Inc. - Alternative Energy - Deals and Alliances Profile

  • $ 250
  • Company report
  • March 2012
  • by Global Data

SunOpta BioProcess Inc. - Alternative Energy - Deals and Alliances Profile Summary SunOpta BioProcess Inc. (SunOpta) is engaged in designing, construction and operation of biomass conversion equipments. ...

  • Industries : Biopharmaceutical
  • Countries : Canada
Merger & Acquisition in Medical Equipment Industry: Omrix Biopharmaceuticals, Inc.

Merger & Acquisition in Medical Equipment Industry: Omrix Biopharmaceuticals, Inc.

  • $ 250
  • Company report
  • March 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Omrix Biopharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report

Omrix Biopharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report

  • $ 125
  • Company report
  • February 2012
  • by ICD Research

Synopsis ICD Research's "Omrix Biopharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile ...

  • Industries : Biopharmaceutical
  • Countries : United States, Israel
Biopharmaceutical Industry: Nabi Biopharmaceuticals - Strategy and SWOT Report

Biopharmaceutical Industry: Nabi Biopharmaceuticals - Strategy and SWOT Report

  • $ 175
  • Company report
  • December 2011
  • by MarketLine

The Nabi Biopharmaceuticals - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive industry player data and information. The market research report covers the firm ?s structure, operation, ...

  • Industries : Biopharmaceutical
  • Countries : United States
Nabi Biopharmaceuticals

Nabi Biopharmaceuticals

  • $ 175
  • Company report
  • December 2011
  • by MarketLine

Nabi Biopharmaceuticals - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings ...

  • Industries : Biopharmaceutical
  • Countries : United States
Nabi Biopharmaceuticals SWOT

Nabi Biopharmaceuticals SWOT

  • $ 175
  • Company report
  • December 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Nabi Biopharmaceuticals (Nabi) is engaged in the ...

  • Industries : Biopharmaceutical
  • Countries : United States
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market

Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market

  • $ 3 500
  • Industry report
  • December 2011
  • by GBI Research

Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market Summary GBI Research, the leading business ...

  • Industries : Biopharmaceutical
  • Countries : World, United States, Europe
Enzymes: United States : Focus report

Enzymes: United States : Focus report

  • $ 600
  • Industry report
  • December 2011
  • by Freedonia Focus

Report Description This report discusses US enzyme demand for the years 2005 and 2010, with forecasts for 2015. Topics covered include market size, product and market segmentation, environmental and regulatory ...

  • Industries : Biopharmaceutical
  • Countries : United States
Next-Generation Antibody Therapies: Pipeline and Market 2011-2021

Next-Generation Antibody Therapies: Pipeline and Market 2011-2021

  • $ 2 641
  • Industry report
  • November 2011
  • by Visiongain

Report Details What are the prospects for emerging antibody technologies? Visiongain's report shows you potential revenues to 2021, discussing R&D trends and opportunities.  A new generation of therapeutic ...

  • Industries : Biopharmaceutical
  • Countries : United States
Dyax Corporation SWOT

Dyax Corporation SWOT

  • $ 175
  • Company report
  • October 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Dyax, a development stage biopharmaceutical firm ...

  • Industries : Biopharmaceutical
  • Countries : United States
Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020)

Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020)

  • $ 1 200
  • Industry report
  • October 2011
  • by International Market Analysis Research and Consult

With sales worth US$ 57 Million in 2010, biosimilars are still far from their billion dollar sales potential that most analysts believe they will generate. This market, however, unlike small molecule generics, ...

  • Industries : Biopharmaceutical
  • Countries : United States
US Biologics  Market

US Biologics  Market

  • $ 4 900
  • Industry report
  • October 2011
  • by Freedonia

US demand to exceed $100 billion by 2015 Demand for biologics will exceed $100 billion in 2015, experiencing continuing strong growth following a decade of double-digit annual increases. Continued growth ...

  • Industries : Biopharmaceutical
  • Countries : United States
Global Protein Purification Reagents Market: An Expanding Role in Biopharmaceutical; Diagnostics; and Basic Biomedical Research

Global Protein Purification Reagents Market: An Expanding Role in Biopharmaceutical; Diagnostics; and Basic Biomedical Research

  • $ 6 000
  • Industry report
  • September 2011
  • by Frost & Sullivan

This research service analyzes the market for protein purification reagents with market sizing and forecasts for sales of tagged protein purification reagents and nontagged protein purification reagents. ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Intellect Neurosciences, Inc. (Symbol:ILNS) SWOT Analysis, Strategy, Revenues and Profits

Intellect Neurosciences, Inc. (Symbol:ILNS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 500
  • Company report
  • September 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
RegeneRx Biopharmaceuticals, Inc. (Symbol:RGN) SWOT Analysis, Strategy, Revenues and Profits

RegeneRx Biopharmaceuticals, Inc. (Symbol:RGN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • September 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Australia, United States
Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - H2 2011

Biopharmaceutical in United States: Micromet, Inc. ? Product Pipeline Review - H2 2011

  • $ 500
  • Company report
  • September 2011
  • by Global Markets Direct

s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using ...

  • Industries : Biopharmaceutical
  • Countries : United States
Omrix Biopharmaceuticals, Inc.: Company Profile and SWOT Analysis

Omrix Biopharmaceuticals, Inc.: Company Profile and SWOT Analysis

  • $ 99
  • Company report
  • September 2011
  • by ICD Research

Synopsis ICD Research's "Omrix Biopharmaceuticals, Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, ...

  • Industries : Biopharmaceutical
  • Countries : United States, Israel
Biopharmaceutical: Proteus Biomedical, Inc.

Biopharmaceutical: Proteus Biomedical, Inc.

  • $ 750
  • Company report
  • August 2011
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the Proteus Biomedical, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product ...

  • Industries : Biopharmaceutical
  • Countries : United States
Micromet, Inc.- Strategy and SWOT Report

Micromet, Inc.- Strategy and SWOT Report

  • $ 175
  • Company report
  • July 2011
  • by MarketLine

Micromet, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings ...

  • Industries : Biopharmaceutical
  • Countries : United States
Pfizer Inc. SWOT

Pfizer Inc. SWOT

  • $ 175
  • Company report
  • July 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Pfizer is the world's premier biopharmaceutical industry ...

  • Industries : Biopharmaceutical
  • Countries : United States
About 1 500 reports

Download Unlimited Documents from Trusted Public Sources

Vaccine Industry in the US

  • Human Papillomavirus Vaccination
  • August 2014
    36 pages
  • Vaccine  

    Cancer  

  • United States  

    North America  

View report >

4 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Amgen Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.